NFKB1 and cancer: In the antioxidant therapeutic approach in cancer cells, the level of ROS must be considered because it can favor the situation in which, in the absence of a proper level of ROS, the cancer therapy can promote carcinogenesis via NF-kB, HIFs, and MAPK activation [27].